Skip to main content
Equibles

Quantinno Capital Management LP

Position in NVCR — NovoCure Ltd

CIK 1759654 NEW YORK, NY
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$33,685,343
+$6,572,945 QoQ
Shares Held
2,223,455
-10.6% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#10
of 217 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Quantinno Capital Management LP holds $1,013,353,919 across 58 Medical Devices names. NVCR ranks #12 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TXG
10x Genomics, Inc.
 5,469,698 $209,708,221
2 EW
Edwards Lifesciences Corp
 1,252,407 $113,292,737
3 GMED
Globus Medical Inc
 1,219,098 $96,320,932
4 ABT
Abbott Laboratories
 788,559 $71,553,843
5 ZBH
Zimmer Biomet Holdings, Inc.
 722,139 $62,168,946
6 SYK
Stryker Corp
 173,466 $54,614,035
7 MDT
Medtronic plc
 631,667 $49,415,309
8 PODD
Insulet Corp
 316,922 $48,251,374

All Filings in NVCR

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,685,343 2,223,455
2026-03-31 $27,112,398 2,487,376
2025-12-31 $25,992,506 2,010,248
2025-09-30 $19,666,410 1,522,168
2025-06-30 $24,362,201 1,368,663
2025-03-31 $17,610,650 988,252
2024-12-31 $8,780,242 294,639
2024-09-30 $3,931,429 251,531
2024-06-30 $6,071,831 354,456
2024-03-31 $895,176 57,273
2023-12-31 $379,849 25,442
2021-03-31 $223,780 1,693
2020-12-31 $292,956 1,693
2020-09-30 $277,273 2,491
2020-03-31 $336,834 5,002